Biognosys
The leader in targeted proteomics and at the forefront of personalized healthcare development..
Launch date
Employees
Market cap
-
Enterprise valuation
CAD27—41m (Dealroom.co estimates Jul 2017.)
Company register number CHE-114.490.102
Schlieren Canton of Zürich (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
* | $3.0m | Series A | |
* | N/A | $1.0m | Early VC |
* | N/A | N/A | Series C |
* | $5.0m | Series C | |
* | N/A | N/A | Series G |
* | CHF75.0m | Acquisition | |
| Total Funding | CAD12.3m | ||
Related Content
Recent News about Biognosys
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.